Cargando…

Rational optimization of a human neutralizing antibody of SARS-CoV-2

SARS-CoV-2 has caused a worldwide epidemic of coronavirus disease 19 (COVID-19). Antibody drugs present an effective weapon for tens of millions of COVID-19 patients. Antibodies disrupting the interactions between the receptor-binding domain (RBD) of SARS-CoV-2 S protein and the angiotensin converti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiao, Wu, Fei, Lin, Dan, Kong, Weikang, Cai, Xueting, Yang, Jie, Sun, Xiaoyan, Cao, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196228/ https://www.ncbi.nlm.nih.gov/pubmed/34147856 http://dx.doi.org/10.1016/j.compbiomed.2021.104550

Ejemplares similares

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes
por: Guo, Yu, et al.
Publicado: (2021)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
por: Shan, Sisi, et al.
Publicado: (2022)

A human SARS-CoV neutralizing antibody against epitope on S2 protein
por: Duan, Jinzhu, et al.
Publicado: (2005)

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
por: Wan, Jinkai, et al.
Publicado: (2020)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

The development of neutralizing antibodies against SARS-CoV-2 and their common features
por: Liu, Liu Daisy, et al.
Publicado: (2020)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Latex Microsphere-Based Bicolor Immunochromatography for Qualitative Detection of Neutralizing Antibody against SARS-CoV-2
por: Liang, Zhanwei, et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
por: Liu, Pengcheng, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibody development strategies
por: BALCIOĞLU, Bertan Koray, et al.
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
por: Guzmán-Bringas, Omar U., et al.
Publicado: (2023)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
por: Li, Lili, et al.
Publicado: (2022)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Sandwich/competitive immuno-sensors on micro-interface for SARS-CoV-2 neutralizing antibodies
por: Lin, Qiuyuan, et al.
Publicado: (2021)

Antibody-like proteins that capture and neutralize SARS-CoV-2
por: Kondo, T., et al.
Publicado: (2020)

Perspectives on the development of neutralizing antibodies against SARS-CoV-2
por: Ho, Mitchell
Publicado: (2020)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
por: Xiaojie, Shi, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Rujas, Edurne, et al.
Publicado: (2021)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
por: Bahlawan, Omar, et al.
Publicado: (2022)

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
por: Huang, Qingrui, et al.
Publicado: (2022)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2
por: Wuo, Michael G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7q203226ktms1vp3ilie3llvb1